Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

The Potential of Robotic-Assisted Gait Training in a Rehabilitation Setting

NCT07529054 · Ludwig Boltzmann Institute for Arthritis and Rehabilitation · Updated 14 April 2026

What is being tested
Lokomat + Vibramoov; Lokomat
For
Stroke; Robotic Assisted Gait Training; Vibration Therapy; Gait Biomechanics
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 40 people. The full rules are on the registry page.
Where
Austria
When
Starts or started 5 Jan 2026, ends Dec 2027. Registered 14 April 2026.
Results
None posted yet.

In the researchers' words

Robotic-assisted gait training (RAGT) devices, such as the Lokomat®, are commonly used to support gait rehabilitation by enabling repetitive, task-specific walking movements. The functional proprioceptive stimulation (FPS) device Vibramoov® represents a novel technology designed to stimulate proprioceptors at the muscle-tendon junction through targeted vibratory stimuli, thereby activating sensorimotor centers in the brain and potentially facilitating movement execution. The aim of this randomized controlled trial is to investigate whether Lokomat® training combined with Vibramoov® leads to greater improvements in qualitative and quantitative gait parameters in stroke patients compared with Lokomat® training alone. The study will be conducted at the Gröbming Rehabilitation Center and will include patients undergoing a four-week neurological inpatient rehabilitation program. Participants will be randomly assigned to an intervention group (Lokomat® + Vibramoov®) or a control group (Lokomat® only), with 20 patients per group. Primary outcomes include the 6-Minute Walk Test (6MWT) and spatiotemporal gait parameters. Additional assessments include functional scores, patient-reported outcome measures, and blood biomarkers. Statistical analyses will be performed depending on data distribution. A follow-up assessment evaluating EQ-5D and PHQ-4 will be conducted six months after…
ClinicalTrials.gov, NCT07529054

Sites

  • Reha-Zentrum GröbmingGröbming, Styria, Austria